Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
GRAIL, Inc., a pioneering entity in the Pharmaceutical Preparation Manufacturing industry, is headquartered in the United States. Founded in 2016, GRAIL has rapidly established itself as a leader in early cancer detection, focusing on innovative multi-cancer early detection (MCED) tests. The company’s flagship product, Galleri™, is designed to identify multiple types of cancer through a simple blood draw, setting it apart in the market with its unique approach to diagnostics.
With a commitment to advancing cancer care, GRAIL operates primarily in the US, while also expanding its reach globally. The company has achieved significant milestones, including partnerships with major healthcare providers, enhancing its position in the competitive landscape of cancer diagnostics. GRAIL’s dedication to innovation and patient-centric solutions underscores its role as a transformative force in the pharmaceutical industry.
-14 vs industry average
GRAIL, Inc.’s score of 28 is lower than 40% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for GRAIL, Inc. yet.
GRAIL, Inc., a US-based company in the Pharmaceutical Preparation Manufacturing industry, has committed to achieving Net-Zero emissions. While specific historical emissions data is not available, GRAIL, Inc. has set a long-term Net-Zero target for all scopes by 2050, with a start year of 2023. They are listed as "Committed" to near-term Science Based Targets initiative (SBTi) targets and have also committed to Net-Zero through the SBTi.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more